Alfares, Israa http://orcid.org/0000-0003-2551-3083
Javaid, Muhammad Shahid
Chen, Zhibin
Anderson, Alison
Antonic-Baker, Ana
Kwan, Patrick
Article History
Accepted: 11 January 2021
First Online: 12 February 2021
Declarations
:
: No specific funding has been received for the conduct of this study and/or preparation of this manuscript. Israa Alfares was supported as a domestic graduate student by the University of Melbourne and in collaboration with Melbourne Brain Centre at Royal Melbourne Hospital. Muhammad Shahid Javaid is supported by a Monash Graduate Scholarship and Monash International Tuition Scholarship. Zhibin Chen is supported by the NHMRC Early Career Fellowship. Patrick Kwan is supported by a Medical Research Future Fund Fellowship (MRF1136427).
: Patrick Kwan has received research grants, consulting fees, and speaker fees from Eisai and UCB Pharma, and speaker fees from LivaNova. Zhibin Chen has received a research grant from UCB Pharma. All other authors have no conflicts of interest relevant to the content of this study.
: Not applicable.
: Not applicable.
: Not applicable.
: Not applicable.
: Not applicable.
: IA was the first reviewer of the first- and second-level screening, designed the protocol, formally screened the search results against the eligibility criteria, conducted data extraction, interpreted the results, and drafted the manuscript. MSJ was the second reviewer of the first-level screening (abstract and title). ZC conducted the statistical analysis. AA-B designed the protocol, conducted data extraction, and drafted the manuscript. AA drafted and critically reviewed the manuscript and supervised the study. PK designed the protocol, interpreted the results, drafted the manuscript, and supervised the study. All authors contributed to the final manuscript.